GILD is oversold on the dailyAnd ready for upward movement for those that missed the train on the upswing.. .We have retraced back down by 61.8%... We are back to pivot point 4 on the Elliott wave.
Trade ideas
GILD Bullish Short Term SetupAfter being rejected by LT moving averages GILD is retesting past low and 200ma daily / 50ma weekly. Biotech sector going in the same direction gaining strength.
Gilead Sciences offering a beautiful long setupTraders, i wanted to share this setup with you that i am trading.
I have had this stock for a while on my watchlist, and was waiting for a correction to buy the dip.
I like to buy low (cheap) in strong stocks showing upside potential.
I particularly was watching the 72$ level (200DMA, 61% fibo this is a big level. The bulls seem to have made a bottom now on this level, and finished the week with a bullish engulfing pattern, engulfing the previous 3 days.
For me this is a sign of higher prices coming in the coming days and maybe weeks.
I am targeting 80$ but keep also an eye on the 76.50$ level. If you like to wait for a small dip into 73.00$ you would get an astonishing R:R of 8:1.
Placing my stop below the the engulfing bar and will manage the trade accordingly.
Hope you like this setup :)
Thanks for reading, and blessings to you all.
GILD Pullback and bounce off previous resistance turned supportGILD Pullback and bounce off previous resistance turned support. Entry 72.80, Stop 71.48, Target 79.87
$GILD - Strong Fib bounce off of .618 areaGILD broke down from ascending channel. Seems to have found Fib support around $72.40 (.618) and rebounded strong.
$GILD potential short term chart pathGILD is within a corrective structure. Should come to resolution soon to continue the uptrend
October 26 Earnings: Gilead - Flying the KiteGilead's core product pipeline, including recent FDA approval is set to soar as key drugs and generics are continuing to outperform.
The company's recent acquisition of KITE Pharma came at the perfect moment with KITE being granted a key drug approval by the FDA.
Gilead's recent cost cutting efforts and R&D focus are to further push growth prospect and boost overall FY guidance.
Generic competition will continue to weigh, however, and limit some blockbuster drug expansion.
I'm starting Gilead with a $90 PT for an extended post-earnings move.
A S/L at $75 around recent area is advised.
I love GILD chart!!I been watching this stock for a while now . It has earnings next month. So, i expect some sideways movement till then but its a good set up. Let's take a look.
Monthly: Macd is crossed up. Price is between Tenkan and Kijun .
Weekly: Macd is crossed up. Price is at resistance bit above Tenkan and Kijun. LT trendline has been broken. Chikou is above price.
Daily: Bullish ichimoku. But macd is crossed down and chikou is below price .
So, I am looking for Breakout on weekly for me to go long. Patience is needed as of now. I want to see the earnings reaction before taking a position. I don't gamble. We'll see if it proves itself bullish again. Otherwise, it's a no go.
Thought to share
Thanks guys
GILD new up rise wave.GILD is about to begin new upward trend takes prices to new high. Watch it for
GILD ... buy/add on the dipthe coo retiring is not the reason for the drop... it may have to a firm taking profits... or the reopening of the false claim act for sales a decade ago... maximum penalty will like be 500-700 million...technicals intact
Gilead holds .382 of recent advanceDecent close on weak day. Held .5 retrace intraday and .382 on close
feels like mid-Julypulled back after new highs, supported by 20 day. Will swing calls on strength Tuesday.
